Brilliant Earth (BRLT): The Margin Story Is Real. The H2 Ask Is Still Big.

Brilliant Earth's Q2 results were a clean quarter. Net sales of $115.1 million beat the high end of guidance, adjusted EBITDA (a proxy for cash earnings before non-cash charges) of $5.8 million was 81% higher than a year ago, and the company raised its full-year profit outlook above last year's actual. That kind of inflection is exactly what the market has been waiting for.

But the factor stack doesn't reward good quarters in isolation. It rewards trajectories that are supported by valuation context, profitability quality, and balance-sheet safety. So let's walk through what the data says about Brilliant Earth today, not what the press release says about last week.

Valuation: Franchise-level discount

Brilliant Earth trades at $1.21 per share, with a market cap of $122.5 million. Enterprise value — market cap minus cash — sits at $63.9 million. The stock generates $449 million in trailing revenue. That works out to 0.14x EV/Sales and 0.28x price-to-sales.

There's no public pure-play jewelry peer on a comparable scale to benchmark directly. Revolve Group, the closest online retail operator with a public comp, trades at 1.34x PS — nearly five times Brilliant Earth's multiple on a sales basis. Even Lands'End, a deeply discounted catalog and apparel name, trades at a higher valuation. Brilliant Earth is priced as if the business is permanently impaired. That's the market's current vote, not a fundamental verdict.

The implication is clear: if the company hits the new $13 million–$15 million adjusted EBITDA guidance, the current price implies roughly a 5x EV/EBITDA multiple. That's cheap for a consumer brand with a debt-free balance sheet, but it's only cheap if the EBITDA actually materializes.

Growth: Revenue acceleration is modest, ASP is the real engine

The growth factor is mixed. Revenue growth of 6.4% year-over-year on a trailing basis is fine, not exceptional. Sequential revenue growth of 15.7% quarter-over-quarter looks strong, but jewelry is inherently back-loaded — Q4 is always the biggest quarter, so Q2-to-Q3 and Q3-to-Q4 jumps are mechanical.

What's worth paying attention to is the revenue mix. Average selling price (ASP) grew 8% year-over-year to $2,238. Total orders fell 2% year-over-year, but orders above $500 grew 5%, and fine jewelry bookings surged 32%. Engagement rings — the product category that drives the bulk of transaction volume — stayed flat, while wedding/anniversary bands and fine jewelry both posted double-digit growth.

This is a premiumization trend. The company is selling fewer units at higher prices, and the customer mix is shifting toward higher-income buyers. That's the right direction for margin expansion, and it aligns with what management described as consumer bifurcation: strength at the top, softness at the bottom. Sub-$500 orders represent only a few percent of net sales, so the order decline isn't a signal of demand erosion — it's a deliberate filter.

On a two-year stacked basis, total orders grew 16%. That metric smooths out the one-off tariff acceleration that boosted Q2 2025. It's a cleaner read on underlying demand.

Profitability: The margin expansion is the headline

Gross margin was 57.9% in Q2, up 360 basis points sequentially from Q1 and only about 40 basis points below Q2 2025. The sequential improvement is the key data point. Q1 gross margin was dragged down by elevated metal costs and tariff impacts that front-loaded inventory purchases in the prior year. Management used dynamic pricing, product specification changes, and procurement efficiencies to push margins back into the high-50s range.

Operating expense leverage was even more pronounced. Total operating expenses were 57.5% of net sales versus 59.4% a year ago — a 190-basis-point improvement. Marketing expense fell from 24.1% of sales to 22.8%, a 130-basis-point reduction. Adjusted operating expenses came in at 53.0% of sales versus 55.5% a year ago.

The combination of stable gross margins and contracting operating expense ratios is what drove the adjusted EBITDA beat. Q2 EBITDA of $5.8 million followed Q1 EBITDA of negative $4.7 million. That's a $10.5 million swing in one quarter.

But the TTM operating margin is still negative 2.0%, ROIC sits at negative 17.8%, and ROE is negative 32.8%. The profitability factor hasn't flipped to strong yet — it's moving in the right direction from deeply negative territory.

Safety: Debt-free, cash-rich, but FCF is thin

The balance sheet is the cleanest factor in the stack. Total debt is zero. Cash and equivalents stand at $75 million. The company ended the quarter with a net cash position — no leverage, no maturities to manage, no refinancing risk. That's a meaningful advantage for a company in a sector where metal price volatility and tariff uncertainty can strain working capital.

Free cash flow on a TTM basis is $2.9 million, down 77% year-over-year. That decline reflects the heavy Q4 2025 capital base, including inventory buildup and showroom expansion. Capital expenditures were $3.5 million over the trailing twelve months. Inventory stands at $53.3 million, and inventory turns remain at approximately 4x, well above the jewelry industry average. The company also reduced inventory by roughly $1 million sequentially in Q2, suggesting no excess build.

The current ratio is 157.6% and the quick ratio is 97.3%. Liquidity is adequate, and with $75 million in cash against a $122.5 million market cap, nearly 60% of equity value is already sitting in the bank.

Momentum: The stock just woke up

RSI sits at 58.8 — neutral territory, no overbought signal. The stock is trading above its 50-day moving average ($1.15) but well below its 200-day average ($1.53). MACD is slightly negative at -0.017, suggesting the trend hasn't fully flipped bullish.

The price action tells a clearer story than the indicators. The stock jumped 16.4% on the day of the Q2 report, and is up 9% over five days. Year-to-date, it's down 31%. Over the past 120 days, down 20%. The stock has been in a sustained decline and the earnings pop was a sharp counter move, not a trend reversal. The 52-week range is $1.00 to $3.10. At $1.21, the stock is still near the bottom of its annual band.

The guidance arithmetic

This is where the story gets interesting. Management raised full-year adjusted EBITDA guidance to $13 million–$15 million, above fiscal 2025's actual $12 million. The previous full-year 2026 guidance, given in March, was qualitative: "profitable, slightly lower than 2025."

The H2 ask is substantial. H1 2026 delivered $1.1 million in combined adjusted EBITDA ($5.8M in Q2 less $4.7M in Q1). To hit the midpoint of the new guidance ($14M), the company needs $12.9 million over the next two quarters. Q3 guidance is $3 million–$5 million. That means Q4 implied EBITDA would need to be roughly $8 million–$10 million.

Q4 is historically Brilliant Earth's strongest quarter — holiday season, wedding rush, Q4 2025 saw record quarterly sales. But $8M–$10M in a single quarter would be 30–40% of the full-year total. The arithmetic works only if the premium shift holds through the holidays and operating expense discipline continues.

The verdict

Brilliant Earth's Q2 quarter was a genuine improvement. The margin trajectory is real, the consumer mix is shifting to higher-value transactions, and the balance sheet is clean. The stock trades at a deep discount to any reasonable revenue or earnings multiple — 0.14x EV/Sales, effectively 5x the midpoint of the raised EBITDA guidance.

But the factor stack hasn't flipped to Strong Buy territory yet. Revenue growth is modest. Profitability metrics on a trailing basis are still weak. Momentum is recovering from a 31% YTD decline, not establishing a new trend. AInvest's aggregate signal labels the stock a Hold, which aligns with the mixed factor picture: strong valuation and safety, improving but unproven profitability, and neutral momentum.

The setup fits a contrarian growth sleeve. If the company delivers on $13M–$15M in EBITDA, the current valuation is a gift. If it delivers $10M–$12M — still a reasonable year — the stock has moved but the thesis hasn't broken. If it misses to $8M–$10M, the market's deep skepticism was justified and the stock has further to fall.

The trigger to watch: Q4 results in late March 2027 will tell the story. Until then, the factor stack says the improvement is real but unconfirmed, the valuation is compelling but untested, and the risk-reward is tilted toward patience rather than conviction.